Aclaris Therapeutics, Inc. ACRS
NASDAQ · United States · Health Technology
$5.26-0.02 (-0.38%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.15 | -0.16 | +6.3% | $1.63M | +17.8% | -7.1%$6.36→$5.91 |
| Q1 2026 | 2026-05-07 | -0.15 | -0.16 | +6.3% | — | — | +3.1%$4.78→$4.93 |
| Q4 2025 | 2026-02-26 | -0.16 | -0.15 | -6.7% | — | — | -13.3%$3.31→$2.87 |
| Q3 2025 | 2025-11-06 | -0.12 | -0.13 | +7.7% | — | — | +2.7%$2.26→$2.32 |
| Q4 2023 | 2024-02-27 | -0.02 | -0.39 | +94.9% | — | — | — |
| Q3 2023 | 2023-11-06 | -0.41 | -0.49 | +16.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.